News · Approval
1,552 stories
Aug 14, 26After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?
Aug 14, 26‘We’re not afraid of competition’: BioCryst CEO sets out strategy after scrapping internal discovery
Aug 14, 26MapLight dims preclinical programs to make phase 3-ready schizophrenia drug shine brighter
Aug 13, 26Meet Motivista: Click Therapeutics debuts first-of-its-kind schizophrenia digital therapeutic
Aug 13, 26PTC’s $211M bid wins Sangamo auction, teeing up ‘special opportunity’ to enter Fabry market
Aug 13, 26Cullinan tees up J&J fight—and $100M payday—as Taiho-partnered drug hits phase 3 cancer goal